Gold Rates Steady As Firm Dollar Offsets Rise In COVID-19 Cases
Gold prices held steady on Wednesday, supported by concerns stemming from a surge in coronavirus infections in Beijing but with hopes for a potential COVID-19 drug and a stronger US dollar limiting their advance. Spot gold was flat at $1,727.26 per ounce by 12:47 pm, holding a narrow $6 range. US gold futures were mostly unchanged at $1,736.60 per ounce. "The attention remains elsewhere, mostly equity markets. However, COVID-19 nerves as Beijing shutdowns extend should offer support on any dips," said Jeffrey Halley, senior market analyst at OANDA.
Beijing officials reported several new COVID-19 cases for the sixth consecutive day, while new infections hit record highs in six US states on Tuesday.
Offsetting upwards pressure on gold, the dollar rose 0.1 per cent against its rivals, making the metal more expensive for holders of other currencies.
A record increase in US retail sales in May supported views the US recession might be drawing to an end, with upbeat trial results for a COVID-19 treatment further aiding investor sentiment.
Geopolitical tensions and additional stimulus measures from global central banks also offered some support to bullion, which is often used as a safe store of value during times of political and financial uncertainty.
India reported 20 of its soldiers had been killed in clashes with Chinese troops at Galwan Valley in Ladakh, while tensions between North and South Korea simmered after North Korea blew up a joint liaison office set up as part of a 2018 peace agreement.
"On the one hand, we have geopolitical flashpoints igniting all over the map. On the other, the US dollar is more robust and competing for those same safe-haven flows," said Stephen Innes, AxiCorp's chief market strategist.
Elsewhere, palladium dropped 0.5 per cent to $1,921.50 per ounce, platinum lost 0.5 per cent to $816.64, while silver was steady at $17.41.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.